Skip to content

Potential value of a Brain-type fatty acid-binding protein test in suspected TIA

Potential value of a Brain-type fatty acid-binding protein test in suspected TIA - B-FABP in TIA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33168
Enrollment
50
Registered
2009-09-22
Start date
2010-01-12
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transient Ischaemic Attack (TIA)

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with symptoms suspected of TIA lasting less than 24 hours, who arrive at the out-patiënt TIA clinic between 3 and 72 hours from symptom onset.

Exclusion criteria

Exclusion criteria: TIA symptom onset >72 hours.

Design outcomes

Primary

MeasureTime frame
Level of B-FABP in the blood of the patiënts Final diagnosis stated by the neurologist

Secondary

MeasureTime frame
n.v.t.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)